# 2026-15951: FDA Warns: Animal Drugs Could Supercharge Human Bacteria Threats

2026-15951, Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to their Microbiological Effects on Bacteria of Human Health Concern; Guidance for Industry; Availability, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-08-06, effective 2026-08-06; PRIA reads it as touching household money (as of 2026-08-13).

- Canonical: https://policyrisk.com/federal-register/2026-15951
- As of: 2026-08-13
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-15951
- Title: Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to their Microbiological Effects on Bacteria of Human Health Concern; Guidance for Industry; Availability
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 50860
- Published: 2026-08-06
- Effective: 2026-08-06
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-08-13

## In one line

FDA Warns: Animal Drugs Could Supercharge Human Bacteria Threats

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for industry (GFI) #152 entitled "Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to their Microbiological Effects on Bacteria of Human Health Concern." This guidance document informs interested parties about FDA's current method for evaluating potential microbiological effects of antimicrobial new animal drugs on bacteria of human health concern as part of the new animal drug application process.

## Effects PRIA read

- Final FDA Method for Drug Application Reviews: benefit, low. The FDA issued final Guidance for Industry (GFI) #152 describing the Agency's current method for evaluating potential microbiological effects of antimicrobial new animal drugs as part of the new animal drug application review process. The guidance was announced in the Federal Register on August 6,…
- Updated Appendix A Drug Importance Rankings: benefit, low. GFI #152 includes Appendix A rankings of medically important antimicrobial drugs into ‘critically important,’ ‘highly important,’ and ‘important’ for human medicine and states these rankings should inform one component of the risk assessment. The final guidance also explains why topical antimicrobi…
- Guidance Is Nonbinding; Alternatives Allowed: benefit, low. The guidance is Level 1 and represents FDA's current thinking, but it does not establish rights and is not binding on FDA or the public; you may use an alternative approach if it satisfies applicable statutes and regulations.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-15951 on federalregister.gov](https://www.federalregister.gov/documents/2026/08/06/2026-15951/evaluating-the-safety-of-antimicrobial-new-animal-drugs-with-regard-to-their-microbiological-effects)
- [2026-15951 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-08-06/pdf/2026-15951.pdf)

## Related
- [Previous: 2026-15950, Certification Under Section 7045(b)(2)(A) of the Department of State, Foreign O…](https://policyrisk.com/federal-register/2026-15950)
- [Next: 2026-15952, Procurement List; Proposed Additions and Deletions](https://policyrisk.com/federal-register/2026-15952)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-15951 (as of 2026-08-13).